Showing 1 - 3 results of 3 for search 'Jeffrey E. Lancet', query time: 0.02s
Refine Results
-
1
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysi... by Jorge E. Cortes, Tara L. Lin, Kobby Asubonteng, Stefan Faderl, Jeffrey E. Lancet, Thomas Prebet
Published 2022-10-01
Article -
2
Integrative molecular subtypes of acute myeloid leukemia by Qianxing Mo, Seongseok Yun, David A. Sallman, Nicole D. Vincelette, Guang Peng, Ling Zhang, Jeffrey E. Lancet, Eric Padron
Published 2023-05-01
Article -
3
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome by Rami S. Komrokji, Avani M. Singh, Najla Al Ali, Onyee Chan, Eric Padron, Kendra Sweet, Andrew Kuykendall, Jeffrey E. Lancet, David A. Sallman
Published 2022-11-01
Article